CATENIBACTERIUM MITSUOKAI PROMOTES TUMOR IMMUNOSUPPRESSION THROUGH METABOLIC REPROGRAMMING OF PMN-MDSC IN HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Guan, Huayu
Zhao, Yutong
Ren, Xuxin
Yang, Qingxia
Li, Shangru
Zheng, Gaomin
Peng, Sui
Kuang, Ming
Zhang, Ying
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1526
引用
收藏
页码：S1569 / S1570
页数：2
相关论文
共 50 条
  • [41] NFYA promotes the anti-tumor effects of gluconeogenesis in hepatocellular carcinoma through the regulation of PCK1 expression
    Tsujimoto, Goki
    Ito, Rin
    Yoshikawa, Kei
    Ueki, Chihiro
    Okada, Nobuhiro
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [42] microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma
    Jiang, Xue-Mei
    Yu, Xiang-Nan
    Liu, Tao-Tao
    Zhu, Hai-Rong
    Shi, Xuan
    Bilegsaikhan, Enkhnaran
    Guo, Hong-Ying
    Song, Guang-Qi
    Weng, Shu-Qiang
    Huang, Xiao-Xi
    Dong, Ling
    Janssen, Harry L. A.
    Shen, Xi-Zhong
    Zhu, Ji-Min
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 105 : 1147 - 1154
  • [43] Hypoxia-induced myeloid derived growth factor promotes hepatocellular carcinoma progression through remodeling tumor microenvironment
    Wang, Xu
    Mao, Jie
    Zhou, Tao
    Chen, Xingyi
    Tu, Haoyang
    Ma, Jinyan
    Li, Yixuan
    Ding, Yushi
    Yang, Yong
    Wu, Hongxi
    Tang, Xinying
    THERANOSTICS, 2021, 11 (01): : 209 - 221
  • [44] Fatty Acid Binding Protein 5 promotes tumor progression through epithelial-mesenchymal transition in hepatocellular carcinoma
    Ohata, Takanori
    Yokoo, Hideki
    Kamiyama, Toshiya
    Wakayama, Kenji
    Orimo, Tatsuya
    Kakisaka, Tatsuhiko
    Tsuruga, Yosuke
    Kamachi, Hirofumi
    Taketomi, Akinobu
    HEPATOLOGY, 2014, 60 : 804A - 805A
  • [45] Cell surface GRP78 promotes tumor cell histone acetylation through metabolic reprogramming: a mechanism which modulates the Warburg effect
    Gopal, Udhayakumar
    Pizzo, Salvatore V.
    ONCOTARGET, 2017, 8 (64) : 107947 - 107963
  • [46] THSWD upregulates the LTF/AMPK/mTOR/Becn1 axis and promotes lysosomal autophagy in hepatocellular carcinoma cells by regulating gut flora and metabolic reprogramming
    Zhu, Zhiqin
    Zuo, Shiqi
    Zhu, Zhiqi
    Wang, Chen
    Du, Yangfeng
    Chen, Fengsheng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 148
  • [47] FOXM1 promotes malignant biological behavior and metabolic reprogramming by targeting SPINK1 in hepatocellular carcinoma and affecting the p53 pathway
    Ding, Xu
    Shi, Jinjun
    Lei, Zhengqing
    Wang, Guoqing
    Fu, Chenchun
    Su, Xiangyu
    Zhu, Guangyu
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2025, 1871 (03):
  • [48] CD63+tumor-associated macrophages drive the progression of hepatocellular carcinoma through the induction of epithelial-mesenchymal transition and lipid reprogramming
    Liu, Shiqi
    Zhang, Shuairan
    Dong, Hang
    Jin, Xiuli
    Sun, Jing
    Zhou, Haonan
    Jin, Yifan
    Li, Yiling
    Wu, Gang
    BMC CANCER, 2024, 24 (01)
  • [49] NFκB mediated elevation of KCNJ11 promotes tumor progression of hepatocellular carcinoma through interaction of lactate dehydrogenase A
    Zhang, Ke
    Mu, Ling
    Ding, Ming-Cui
    Xu, Rui
    Ding, Zhao-Jun
    Liang, Jun
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 495 (01) : 246 - 253
  • [50] NAD(P)HX epimerase downregulation promotes tumor progression through ROS/HIF-1α signaling in hepatocellular carcinoma
    Sun, Bo
    Yu, Lei
    Xu, Cong
    Li, Yi-Ming
    Zhao, Yan-Rong
    Cao, Mo-Mo
    Yang, Lian-Yue
    CANCER SCIENCE, 2021, 112 (07) : 2753 - 2769
12345